2001 and Clinical Research - Drug Discovery Digest

Keys to Success in Vaccine Development for Special Populations

PPD

MAY 11, 2023

From study participants’ consent, to minimizing the patient and caregiver burden, to planning for different needs at different stages of the pediatric immune system, there are many factors to consider when conducting clinical research with this specific population.

Vaccine

Vaccine Clinical Trials Long-Term Care Facilities Trials

The Chemistry Clicked: Two NIH-Supported Researchers Win 2022 Nobel Prize in Chemistry

NIH Director's Blog: Drug Development

OCTOBER 11, 2022

Barry Sharpless, Scripps Research, La Jolla, CA, October 5, 2022 marked the second time that he’s received an early-morning congratulatory call from The Royal Swedish Academy of Sciences. 2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes.

Research

Research Small Molecule Science Clinical Research

Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the European Union

Conversations in Drug Development Trends

MAY 23, 2024

Regulatory Harmonization of Clinical Trials in the EU The EU-CTR repealed the Clinical Trial Directive 2001/20/EC (CTD) and national implementing legislation in the EU Member States on 31 January 2022.

Trials

Trials Clinical Trials Therapies Regulations

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials

Alta Sciences

SEPTEMBER 13, 2023

Altasciences’ experienced clinical researchers can accommodate and advise you on your pain management and treatment contributions, the needs of your therapeutic studies, how to best utilize various pain models, and evaluate and assess the efficacy of your treatment. billion people that suffer from chronic pain, globally , (51.6

Clinical Trials

Clinical Trials Treatment Trials Pharmacokinetics

Where is the promise for plant-based medicines? Part 2: Psilocybin

Drug Discovery World

AUGUST 24, 2023

Within the debate, an e-petition was presented, which closed in February 2023 and received 11,824 signatures, and called on the government to reschedule psilocybin for medical research on untreatable conditions to Schedule II of the Misuse of Drugs Regulations 2001. million in seed funding, bringing the total to date up to £2.5

Clinical Trials

Clinical Trials Treatment Regulations Trials

Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.

The Pharma Data

JANUARY 10, 2021

SH ) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. At present, Chiauranib has globally applied for more than 40 patents of invention. About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.

Clinical Trials

Clinical Trials Trials Treatment Small Molecule

New horizon for cancer innovation

Drug Discovery World

OCTOBER 7, 2022

This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. . Recent studies have shown that academic inventors contributed 37% of cancer medicines between 2001-2019.

Pharma Companies

Pharma Companies Science Research Drug Development

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

OCTOBER 16, 2023

CellProthera selected the UK centres for their excellence in the conduct of clinical research with dedicated staff, equipment, availability of imaging platforms and high interest in cell therapy cardiovascular trials especially University Hospital of Birmingham equipped with a bi-plane Cathlab.

Drugs

Drugs Science Therapies Targeted Protein Degradation

Human neuronal cells: possibilities in drug safety testing

Drug Target Review

SEPTEMBER 26, 2023

She completed a PhD at Durham University which focused on investigating the mechanisms of cardiotoxicity of cancer therapies using clinically relevant in vitro human models of cardiac physiology paired with novel methodologies to evaluate structural and functional toxicities. 2001 Sep;24(9):517–26. Adv Drug Deliv Rev. Trends Neurosci.

Drugs

Drugs FDA Disease Animal Testing

Chipscreen and HISUN reach a strategic cooperation

The Pharma Data

DECEMBER 15, 2020

SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. Such cooperation will rapidly expand the coverage of the drug product after its launch, providing professional pharmaceutical services to doctors and patients, and benefit more patients.”

Pharmaceuticals

Pharmaceuticals Small Molecule Clinical Trials Production

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Agency IQ

APRIL 8, 2024

For BA/BE studies that do not require INDs (a majority of those used in support of generic drug applications), only a subset of FDA’s regulations regarding clinical research apply. This was an area that FDA investigators recently interviewed by the U.S. Government Accountability Office (GAO) flagged as a major concern.

FDA

FDA Production Regulations Vaccine

ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors

The Pharma Data

OCTOBER 18, 2020

Founded in 2001, ReWalk has headquarters in the United States, Israel and Germany. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. ReWalk® is a registered trademark of ReWalk Robotics Ltd.

Compliance

Compliance Production Nurses Government

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

MAY 13, 2021

2001 Nov 16;12(16):3549-52. Clinical Research Strategies for Fructose Metabolism. 2001 Sep;30(3):765-85. Measuring visceral and hepatic fat in clinical practice and clinical research. Colantuoni C, Schwenker J, McCarthy J, Rada P, Ladenheim B, Cadet JL, Schwartz GJ, Moran TH, Hoebel BG. Neuroreport.

Disease

Disease Production Testimonials Science

How the Fifty States View Electronic Data as a “Product”

Drug & Device Law

JULY 31, 2023

2001); Isham v. 2001), relied on these other statutes to hold that a road could not be a “product”). 2001) (applying Illinois law); Serpico v. Huntington Ingalls Inc. , 3d 1170, 1173 (9th Cir. 2016) (citations omitted). Accord Stark v. Armstrong World Industries, Inc. , 371, 377 (6th Cir. PADI Worldwide Corp. Engelhardt v.

Production

Production International Trials Government

Drug Discovery Digest

Keys to Success in Vaccine Development for Special Populations

The Chemistry Clicked: Two NIH-Supported Researchers Win 2022 Nobel Prize in Chemistry

Trending Sources

Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the European Union

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials

Where is the promise for plant-based medicines? Part 2: Psilocybin

Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.

New horizon for cancer innovation

Where is the drug discovery expertise happening in the UK?

Human neuronal cells: possibilities in drug safety testing

Chipscreen and HISUN reach a strategic cooperation

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors

Let's Quit Sugar With Audiobook – Let's Quit Sugar

How the Fifty States View Electronic Data as a “Product”

Stay Connected